2Godwin J E, Kopecky K J, Head D R, et al. A doubleblind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreatedacute myeloid leukemia:a Southwest Oncology Group study. Blood, 1998, 91:3607-3615.
3Leith C P, Kpecky K J, Godwin J, et al. Acute myeloid leukemia in the elderly:a ssessment of multigrug resistance (MDR-1)and cytogenenties distinguishes biologic subgroups with remarkable distinct responses to standard chemotherapy: a Southwest Oncology G
4Cassileth P A, Harrington D P, Appelbaum F R, et al. Chemotherapu compared with autologous or allogenenic bone marrow transplantation in the management of acute myeloid leukemia in first remission. N Engl J Med, 1998, 339:1649-1656.
5Estey E. Treatment of refractory AML. Leukemia, 1996, 10:932-932.
6HIddeman W, Kern W, Schoch C, et al. Management of acute myeloid leukemia in elderly patients. J Clin Onc, 1999, 17:3569-3576.
7Benzin J, Lang K, Earle C C, et al. The outcomes and costs of acute myeloid leukemia among the elderly. Arch Inter Med, 2002, 22:162:1597-1603.
